ARCHIVES

Afinitor Extends PFS In Women With EGFR-2 Positive Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

New Screening Tool Helps GP ID Hereditary BC Risk

October 27, 2006

Women’s Health Trial Committee Hears New Analysis Of Vanguard Groups, Other Data

January 1, 1988

The Cancer Letter’s Paul Goldberg Wins Journalism Award

April 10, 2009

Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”.

February 15, 2002

Group trials need prioritization, review, NCI official says.

July 25, 2003

Two Papers Evaluate CyberKnife Survival Rates and Tolerability

November 29, 2013